Brind.

Morgan Stanley assigned an Equal-Weight rating to Genmab on July 3, 2025.

1 report, 0 independent Updated Jul 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Genmab Morgan Stanley

Keep exploring

The entities involved

Genmab
Danish healthcare company
- Genmab, a Danish biotechnology company, granted stock units and warrants via its Board of Directors on September 1, 2026.Thu 21:07
Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

Morgan Stanley issued an equal weight rating on GMR Solutions Inc. on August 1, 2026.Aug 31
Morgan Stanley lowered its rating for CAE Inc from equal weight to underweight on August 27, 2026.Aug 27
Morgan Stanley analyst provides Overweight rating for SpaceX.Sep 5
Morgan Stanley issued an underweight rating on Hess Midstream Partners LP.Aug 19
Morgan Stanley issued an Underweight rating on Cipla, which is driving US commercialization.Sep 4

Coverage

Newest first; wire copies grouped

Jul 3Unknown outlet